Kenneth Jensen

MD, clinical associate professor The Danish Centre for Particle Therapy, Aarhus University Hospital kennjens@rm.dk
Research interests

DK: Proton-strålebehandling. Hoved-halskræft. Bivirkninger. Patient rapporterede endepunkter. Socio-økonomiske endepunkter. Synkeproblemer. Understøttende behandling. Onko-geriatri.

UK: Proton-radio treatment. Head and neck cancer. Side effects. Patient-reported ends. Socio-economic ends. Difficulties in swallowing. Supportive treatment. Onco-geriatric. 

 Workgroups Publications
  • Sharma MB, Jensen K, Friborg J, Smulders B, Andersen E, Samsøe E, Johansen J, Hansen CR, Andersen M, Nielsen MS, Filtenborg MV, Ren J, Korreman SS, Overgaard J, Grau C Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008-2015. A DAHANCA study Acta Oncol . 2022 Feb;61(2):120-126 2022
  • R Argota-Perez, M B Sharma, U V Elstrøm, D S Møller, C Grau, K Jensen, A I S Holm, S S Korreman Dose and robustness comparison of nominal, daily and accumulated doses for photon and proton treatment of sinonasal cancer Radiother Oncol. 2022 Aug;173:102-108 2022
  • Jensen K, Al-Farra G, Dejanovic D, Eriksen JG, Loft A, Hansen CR, Pameijer FA, Zukauskaite R, Grau C. Imaging for Target Delineation in Head and Neck Cancer Radiotherapy Semin Nucl Med. 2021 Jan;51(1):59-67. 2021
  • Sharma MB, Argota Perez R, Holm AIS, Korreman SS, Jensen K, Elstrøm UV, Grau C. Air variability in maxillary sinus during radiotherapy for sinonasal carcinoma Clin Transl Radiat Oncol. 2021 Jan 1;27:36-43. 2021
  • Sharma MB, Jensen K, Urbak SF, Funding M, Johansen J, Bechtold D, Amidi A, Eskildsen SF, Jørgensen JOL, Grau C A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer Radiother Oncol. 2020 Oct;151:58-65 2020
  • Sharma MB, Jensen K, Amidi A, Eskildsen SF, Johansen J, Grau C Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life Clin Transl Radiat Oncol. 2020 Sep 12;25:52-60. 2020
  • Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, Smulders B, Andersen E, Nielsen MS, Eriksen JG, Petersen JBB, Elstrøm UV, Holm AI, Farhadi M, Morthorst MH, Skyt PS, Overgaard J, Grau C The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020 Aug 8;151:149-151. 2020
  • Andreassen CN, Eriksen JG, Jensen K, Hansen CR, Sørensen BS, Lassen P, Alsner J, Schack LMH, Overgaard J, Grau C. IMRT - Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncol. 2018 Nov;86:91-99. 2018
  • Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Eriksen JG, Overgaard J NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncol. 2019 Oct;58(10):1410-1415. 2019
  • Saksø M, Jensen K, Andersen M, Hansen CR, Eriksen JG, Overgaard J. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity Radiother Oncol. 2020 Jul;148:65-72 2020